How IT is Transforming Biotech with AI | Anthony Murabito on Data, Security & Innovation #biotech #informationtechnology #aiinbiotech

Can IT really revolutionize a biotech company’s success in the AI era?

In this episode, I talk with Anthony Murabito, VP of IT and Head of Data Security at Wave Life Sciences, to uncover how modern biotech companies are using AI to accelerate research, enhance security, and optimize workflows. Please visit our website to get more information: https://swangroup.net/

We dive into the real-world role of IT in biotech from crafting AI policies to managing data protection and aligning IT with R&D and commercial goals. Whether it’s pharmacology modeling or auto-reporting for sales teams, AI is reshaping everything.

If you're in life sciences, tech, or leadership, this conversation will give you practical tips, a new mindset, and fresh strategies to maximize IT’s impact. Subscribe to hear more on AI in biotech, data governance, and tech-driven leadership.

Links from this episode:

✅ Get to know more about Anthony Murabito: https://www.linkedin.com/in/tonymurabito

✅ Learn more about Wave Life Sciences: https://www.wavelifesciences.com

🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.

https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1

🔗 Stay Connected With Us.

Linkedin: https://www.linkedin.com/company/the-swan-group/

Website: https://swangroup.net/

=============================

🎬Suggested videos for you:

▶️ https://www.youtube.com/watch?v=NQN6X206A94

▶️ https://www.youtube.com/watch?v=ZWXIIe66-kI

▶️ https://www.youtube.com/watch?v=T6EzJ1F_6pg

▶️ https://www.youtube.com/watch?v=be8szNVFrNk

▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM

=================================

🔎 Related Phrases:

How IT is Transforming Biotech with AI, Anthony Murabito on Data, Security & Innovation, How AI Is Transforming Biotech Companies, Role Of IT In Biotech, AI And Data Security In Life Sciences, IT Leadership In Biotech Startups, Crafting AI Policy In Biotech, AI In Drug Discovery Workflows, Biotech Digital Transformation With AI, AI Governance Strategies For Biotech, How IT Supports R&D Teams, Biotech And AI Use Cases, Securing Biotech Data With AI, Commercial AI Tools In Life Sciences

#biotech #informationtechnology #aiinbiotech #datasecurity #anthonymurabito #biotechleadership #wave lifesciences #aiintegration #digitaltransformation #biotechit #techleadership #aipolicies #cybersecurity #biotechresearch #pharmacologyai

Fixing Gene Therapy Access With AI | How Genoplex Is Helping Patients Get Treated Faster #genetherapy #biotech #healthcareai

What if gene therapy could cure your disease, but you never made it to the treatment center in time? In this episode of Biotech Bytes, we dive into that real and urgent problem with Christopher Leidli, CEO of Genoplex.ai. Chris shares how his company uses AI to match patients with advanced therapies and treatment centers faster than ever before. Please visit our website to get more information: https://swangroup.net/

We talk about the logistics, the outdated systems, and the patient pain points that make accessing cutting-edge gene and cell therapies so difficult. From working at biotech giants like Amgen and J&J to launching a startup to bridge the access gap, Chris has seen every side of this challenge.

You'll learn the difference between gene therapy, cell therapy, and T-cell therapy, the current FDA-approved treatments, and why health equity is still a major barrier. We also get into how Genoplex’s platform works and why AI could be the key to helping patients get lifesaving care when it matters most.

🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.

https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1

🔗 Stay Connected With Us.

Linkedin: https://www.linkedin.com/company/the-swan-group/

Website: https://swangroup.net/

=============================

🎬Suggested videos for you:

▶️ https://www.youtube.com/watch?v=NQN6X206A94
▶️ https://www.youtube.com/watch?v=ZWXIIe66-kI
▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM
▶️ https://www.youtube.com/watch?v=mqpB3pGywkU
▶️ https://www.youtube.com/watch?v=w9QyuG6p3Ys

=============================

✅ About Biotech Bytes by The Swan Group.

Welcome to The Swan Group’s Pharmaceutical Industry Podcast Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders, where expertise meets innovation at a crossroads in the pharma and life sciences.

With over four decades of rich industry history, our podcast delves into the critical topics and trends shaping the pharmaceutical landscape. Each episode brings insights from industry leaders, discussions on best practices, and an in-depth look at the strategies driving success in the life sciences sector.

Join us as we explore the pulse of pharma through the lens of The Swan Group’s extensive network and specialized recruitment know-how.

🔔 Unlock the secrets of pharma success—subscribe for expert tips, industry leader interviews, innovative strategies, and revolutionary trends!

https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1

=================================

🔎 Related Phrases:

Fixing Gene Therapy Access With AI, How Genoplex Is Helping Patients Get Treated Faster, How Genoplex Helps Patients Find Treatment, Gene And Cell Therapy Explained, Difference Between Gene And Cell Therapy, Why Patients Can't Access Gene Therapy, How Ai Is Transforming Healthcare Access, Fda Approved Gene Therapy Drugs 2025, Using Ai For Medical Referrals, Health Equity In Biotech, Gene Therapy For Sickle Cell Disease

#genetherapy #biotech #

The Future Of Biotech IT: AI, Cybersecurity & Low-Code Platforms | Steve Eichorn #biotech #aiinbiotech #cybersecurity

How is AI transforming the future of biotech today, not just in labs but in IT departments too? Please visit our website to get more information: https://swangroup.net/

In this episode, I sit down with Steve Eichorn, CIO of Cytiva, to explore how artificial intelligence, cybersecurity, and low-code platforms are reshaping biotech from the inside out.

Specifically, this episode highlights the following themes:
✅ How AI is improving biotech operations and clinical processes
✅ The growing importance of cybersecurity in an AI-driven world
✅ Why low-code development is shaping the future of IT and business collaboration

Steve shares his unique journey from finance to leading global IT and explains how AI is accelerating drug development, why low-code tools are changing how teams build solutions, and how security is now a core part of innovation.

We also talk about how tech leaders are breaking down data silos, building more collaborative cultures, and preparing for the digital future of healthcare.

If you’re in biotech, tech, or healthcare, this conversation is full of insights you won’t want to miss.

Links from this episode:
✅ Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
✅ Get to know more about Steve Eichorn: https://www.linkedin.com/in/steve-eichorn-he-his-him-68b8105